About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Down's Syndrome Testing Now in Several European Markets

by Krishna Bora on August 21, 2012 at 10:56 AM
Font : A-A+

Down's Syndrome Testing Now in Several European Markets

A new prenatal test for Down's syndrome hit the market in Germany and several other European countries Monday, the manufacturer said, amid a controversy over whether it could lead to more abortions.

The product, marketed as PrenaTest and manufactured by German life sciences company LifeCodexx, "is targeted exclusively toward women in their 12th week of pregnancy and beyond who are at an increased risk" of delivering a child with Down's syndrome, the company said in a statement.

Advertisement

The test which involves screening pregnant women's blood samples for the presence of foetal Down's syndrome -- also known as trisomy 21 -- had recently come under fire from rights groups concerned about abortions.

In June, the international federation of Down's syndrome organisations objected to such testing at the European Court of Human Rights.

The federation, grouping 30 associations in 16 countries, said the Strasbourg court should "recognise the human condition and protect the right to life of people with Down's syndrome and those handicapped".
Advertisement

But last month, Switzerland gave the test the green light with a decision by Swissmedic, the national agency for therapeutic products.

Germany's ombudsman for the disabled, Hubert Huppe, for his part called the test "illegal", fearing a "selection of man by Down's Syndrome", but it did not stop the test from going to market.

Down's syndrome is caused by having an extra copy of chromosome 21 and the risk increases as a woman gets older.

LifeCodexx described their procedure as a "risk-free alternative to common invasive examination methods such as amniocentesis".

Invasive procedures currently used for prenatal diagnosis -- in the 16th week of pregnancy -- pose a one percent risk of foetal loss. The diagnosis is therefore only made available to high risk women, which fails to catch all cases.

Besides Germany and Switzerland, the test is also now available in Austria and Liechtenstein.

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
COVID Toes
International Yoga Day 2022 - 'Yoga for Humanity'
Wearable Devices Are Now Transforming Depression, Multiple Sclerosis, and Epilepsy Management.
View all
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

Most Popular on Medindia

Sanatogen Noscaphene (Noscapine) Turmeric Powder - Health Benefits, Uses & Side Effects Pregnancy Confirmation Calculator Post-Nasal Drip Sinopril (2mg) (Lacidipine) Diaphragmatic Hernia Color Blindness Calculator Selfie Addiction Calculator Blood - Sugar Chart

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use